Page 1 of Clinical Trials for YM178, 32 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study to Investigate the Safety and Effect of Food on the Pharmacokinetics of YM178 in Healthy Volunteers
Last Updated: October 10, 2011
Condition(s): Healthy Volunteer; Pharmacokinetics of YM178
2
Completed
A Study to Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly Volunteers
Last Updated: October 1, 2009
Condition(s): Healthy Volunteer; Pharmacokinetics of YM178
3
Completed
A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers
Last Updated: November 18, 2011
Condition(s): Healthy Subjects; Pharmacokinetics of YM178
4
Completed
A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects
Last Updated: March 4, 2009
Condition(s): Overactive Bladder
5
Completed
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder
Last Updated: May 22, 2012
Condition(s): Urinary Bladder, Overactive
6
Completed
Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder
Last Updated: April 15, 2010
Condition(s): Urinary Bladder, Overactive
7
Completed
Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder
Last Updated: March 23, 2010
Condition(s): Urinary Bladder, Overactive
8
Completed
A Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder
Last Updated: March 31, 2011
Condition(s): Urinary Bladder, Overactive
9
Completed
A Study of YM178 in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
Last Updated: August 24, 2009
Condition(s): Lower Urinary Tract Symptoms; Bladder Outlet Obstruction
10
Completed
A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients
Last Updated: June 8, 2010
Condition(s): Urinary Bladder, Overactive
11
Completed
A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder
Last Updated: June 14, 2010
Condition(s): Urinary Bladder, Overactive
12
Completed
A Study of YM178 in Subjects With Symptoms of Overactive Bladder
Last Updated: October 10, 2011
Condition(s): Urinary Bladder, Overactive
13
Completed
Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers
Last Updated: March 3, 2009
Condition(s): Pharmacokinetics of YM178
14
Completed
A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment
Last Updated: October 1, 2009
Condition(s): Renal Impairment
15
Completed
To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol
Last Updated: November 21, 2011
Condition(s): Pharmacokinetics of Mirabegron; Healthy Subjects
16
Completed
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder
Last Updated: May 10, 2011
Condition(s): Urinary Bladder, Overactive
17
Completed
A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects
Last Updated: April 17, 2012
Condition(s): Pharmacokinetics; Healthy Subjects; Mild and Moderate Hepatic Impairment
18
Completed
A Study of YM178 in Patients With Symptomatic Overactive Bladder
Last Updated: December 13, 2011
Condition(s): Urinary Bladder, Overactive
19
Completed
A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)
Last Updated: April 15, 2008
Condition(s): Overactive Bladder
20
Completed
A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously
Last Updated: February 16, 2011
Condition(s): Healthy Volunteers; Pharmacokinetics of Mirabegron

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=YM178

Page 1 of Clinical Trials for YM178, 32 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About